• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植入式心脏复律除颤器随访:人人都应了解的知识。

Implantable cardioverter-defibrillator follow-up: what everyone needs to know.

作者信息

Wilbur S L, Marchlinski F E

机构信息

Medical College of Pennsylvania Hahnemann University, Philadelphia, Pennsylvania 19102, USA.

出版信息

Cardiol Rev. 1999 Jul-Aug;7(4):176-90. doi: 10.1097/00045415-199907000-00009.

DOI:10.1097/00045415-199907000-00009
PMID:10423669
Abstract

Over the past few years, remarkable advances in the treatment of ventricular tachycardia, ventricular fibrillation, and sudden cardiac death have occurred. One of the most significant treatment modalities has been the addition of the implantable cardioverter-defibrillator (ICD). Because of the rapidly expanding indications for ICD therapy, it is common for internists, family practitioners, emergency room physicians, and general cardiologists to treat defibrillator patients. Basic skills related to ICD follow-up are therefore essential for many physicians. In this review, we will summarize routine device follow-up, provide instructions regarding emergency ICD deactivation, discuss common complications and how to detect them, and answer some frequently asked questions.

摘要

在过去几年中,室性心动过速、心室颤动和心源性猝死的治疗取得了显著进展。最重要的治疗方式之一是增加了植入式心脏复律除颤器(ICD)。由于ICD治疗的适应证迅速扩大,内科医生、家庭医生、急诊室医生和普通心脏病专家治疗除颤器患者的情况很常见。因此,许多医生掌握与ICD随访相关的基本技能至关重要。在这篇综述中,我们将总结常规设备随访,提供有关紧急停用ICD的指导,讨论常见并发症及其检测方法,并回答一些常见问题。

相似文献

1
Implantable cardioverter-defibrillator follow-up: what everyone needs to know.植入式心脏复律除颤器随访:人人都应了解的知识。
Cardiol Rev. 1999 Jul-Aug;7(4):176-90. doi: 10.1097/00045415-199907000-00009.
2
Sudden death in recipients of transvenous implantable cardioverter defibrillator systems: terminal events, predictors, and potential mechanisms.经静脉植入式心脏复律除颤器系统接受者的猝死:终末事件、预测因素及潜在机制。
J Cardiovasc Electrophysiol. 1999 Aug;10(8):1049-56. doi: 10.1111/j.1540-8167.1999.tb00276.x.
3
Mortality benefits and the implantable cardioverter-defibrillator.
Circulation. 1994 Apr;89(4):1851-8. doi: 10.1161/01.cir.89.4.1851.
4
Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.心脏性猝死的预防:植入式心律转复除颤器的作用
Mt Sinai J Med. 2005 Jan;72(1):1-9.
5
Implantable cardioverter-defibrillator: present and future indications.植入式心脏复律除颤器:当前及未来的适应症
Arch Mal Coeur Vaiss. 1996 Feb;89 Spec No 1:141-7.
6
Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.无再同步功能的心脏除颤器植入后患者生存率的决定因素。
Kardiol Pol. 2012;70(11):1099-110.
7
Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.胸壁单极植入式心脏复律除颤器的多中心经验。主动除颤电极导线研究者。
J Am Coll Cardiol. 1996 Aug;28(2):400-10.
8
Indications for an implantable cardioverter defibrillator (ICD).植入式心脏复律除颤器(ICD)的适应症。
Intern Med. 2004 May;43(5):360-7. doi: 10.2169/internalmedicine.43.360.
9
Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.植入式心律转复除颤器治疗后,携带TMEM43基因p.S358L突变的致心律失常性右室心肌病患者的长期临床结局
Circ Arrhythm Electrophysiol. 2016 Mar;9(3). doi: 10.1161/CIRCEP.115.003589.
10
What risk should justify implantable cardioverter defibrillator therapy?何种风险足以证明植入式心脏复律除颤器治疗的合理性?
Am J Cardiol. 1999 Mar 11;83(5B):101D-103D. doi: 10.1016/s0002-9149(98)01010-8.